After weight-loss surgery in people with severe obesity, two specific blood proteins rise within four weeks, and higher levels of these proteins are linked to greater weight loss one year later. This...
Mechanism
Synthesis from 1 study
After weight-loss surgery, the gut releases more OXM, which tells fat cells to break down and release energy. The liver turns that energy into ketones and sends out FGF21, which makes brown fat burn calories as heat. This process keeps burning extra energy for months, helping people lose weight and...
Most probable mechanism
After surgery, the gut releases more OXM, which tricks the body into thinking it’s full and starts burning fat. Fat cells release fatty acids, which go to the liver and get turned into ketones. The liver then releases FGF21, which tells brown fat to burn even more energy as heat. This process keeps burning calories long after surgery, helping people lose weight and keep it off.
Roux-en-Y gastric bypass increases postprandial secretion of oxyntomodulin (OXM) from intestinal L-cells due to altered nutrient flow and gut hormone dynamics
OXM activates glucagon receptors on white adipose tissue, triggering cAMP/PKA signaling that phosphorylates hormone-sensitive lipase and releases free fatty acids into circulation
Free fatty acids are taken up by the liver, activating PPARα and increasing expression of CPT1a and HMGCS2, which drive fatty acid oxidation and ketone body production
Hepatic ketogenesis and glucagon receptor signaling induce transcription and secretion of fibroblast growth factor 21 (FGF21) from hepatocytes
FGF21 acts on brown adipose tissue to upregulate UCP1 expression and enhance mitochondrial uncoupling, increasing energy expenditure as heat
Sustained elevation of OXM and FGF21 maintains lipolysis, ketogenesis, and thermogenesis, creating a persistent negative energy balance that drives long-term weight loss
Less supported by current evidence, but not ruled out
After surgery, higher levels of OXM and FGF21 cause fat tissue to release more adiponectin, which tells the liver to burn fat instead of storing it, helping reduce fatty liver and improve metabolism.
Elevated OXM and FGF21 stimulate adiponectin secretion from white adipose tissue
Adiponectin binds to receptors on hepatocytes, activating AMPK and PPARα signaling pathways
AMPK/PPARα activation increases fatty acid oxidation and suppresses de novo lipogenesis in the liver
Reduced hepatic lipid content and improved insulin sensitivity contribute to sustained metabolic improvement and weight loss
After surgery, fat breakdown releases fatty acids that attract special immune cells to white fat, which then signal fat cells to behave like heat-burning brown fat, increasing calorie use.
Lipolysis-induced free fatty acids act as chemoattractants for eosinophils and type 2 innate lymphoid cells in white adipose tissue
Infiltrating immune cells secrete interleukin-4 and interleukin-13, which polarize macrophages to an M2 phenotype
M2 macrophages and cytokines induce UCP1 expression in white adipocytes, promoting thermogenic beiging
Beiging of white adipose tissue increases local energy expenditure, contributing to long-term fat loss
Evidence from Studies
Supporting (1)
Community contributions welcome
The dual GLP-1/glucagon receptor agonist G49 mimics bariatric surgery effects by inducing metabolic rewiring and inter-organ crosstalk
Contradicting (0)
Community contributions welcome
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.